Strides Pharma to launch Potassium Chloride Extended-Release markets in US market

Pharmaceutical Strides Pharma Science Ltd said wholly owned subsidiary Vensun Pharmaceuticals and partner Pharmaceutics International received approval from the United States Food and Drug Administration to launch a generic equivalent of Merck’s potassium chloride extended-release tablets. The drug will be launched in the doses of 750 mg, 1,125 mg and 1,500 mg. Strides Pharma already […]

Strides Pharma receives USFDA nod for its greenfield oral facility in Singapore

Pharmaceutical major Strides Pharma Science Ltd said it received approval from the United States  Food and Administration for its greenfield oral medication facility in Singapore, giving a boost to the company’s efforts to bid for US government contracts. The new unit will help the company supply its products to US government agencies as Singapore is […]

Strides Pharma Bangalore plant passes USFDA inspection with zero observations

Strides Pharma said the US Food & Drug Administration completed an inspection of the company’s primary manufacturing facility in India with zero adverse observations. The company‚Äôs formulations facility at KRSG Gardens in Bangalore was inspected by the USFDA for good manufacturing practices in August 2018 and November 2018. Strides Pharma said it received the Establishment […]

Strides Shasun denies rumors of auditor resignation

Pharma major Strides Shasun denied rumors that its auditors had resigned. The rumors, coming close on the heels of a similar development at Manpasand Beverages, had impacted the company’s share price today morning. Shares of Strides Shasun fell to a low of Rs 397 compared to the close of Rs 423 yesterday, before making up […]

Strides Shasun, Apotex to merge Australian ops to create biggest generics player

Pharma player Strides Shasun said it has agreed in principle to merge its Australian business with the Australian operations of peer Apotex. Both have substantial businesses in Australia; Strides under the Arrow brand and Apotex under its primary brand. The merger will enable Strides, through the merged business, to become the leading player in the […]

Strides Shasun launches generic version of Merck’s allergy drug in US

Pharma manufacturer Strides Shasun said it received approval from the United States Food and Drug Administration to sell a generic version of Merck’s Periactin tablets. The US market for Cyproheptadine Hydrochloride Tablets is approximately USD 20 Million, according to IQVIA, the company said. The drug is an antihistamine used to relieve allergy symptoms such as […]

Strides Shasun launches OTC version of ulcer drug Ranitidine in the US

Pharma major Strides Shasun said it has decided to launch the ‘over the counter’ version of ulcer drug Ranitidine in 150 mg dosage in the US markets immediately. Strides Shasun is already a key player in the US Ranitidine market with 32% market share through its prescription version in 150 mg and 300 mg doses. […]

Cipla, Strides Shasun launch HIV drug in the US after patent expires

Cipla and Strides Shasun, two Indian pharmaceutical companies, both said they have started shipping generic versions of Gilead Sciences’ HIV drug Viread after patent protection expired last week. Viread is among the bigger pharmaceutical drugs in the US and has sales of around $725 mln (Rs 4,650 cr) in the US every year. The patent […]

Eris Lifesciences completes acquisition of Strides Shasun India generics ops

Pharma company Eris LifeSciences said it has completed its purchase of the India branded generics of Strides Shasun for Rs 500 cr in cash. “We now wish to confirm that the transaction ahs achieved closure,” said Eris Lifesciences. Last month, Strides Shasun said it was selling the India branded business as part of its portfolio […]

Strides Shasun says Eris deal to help reprioritize business, lower debt

Pharma major Strides Shasun said it agreed to sell its India branded generics business to Eris LifeSciences Limited for Rs 500 cr in cash. “This transaction is the outcome of the company’s portfolio reprioritization, to focus more sharply on larger regulated markets,” it said. The India branded generics business being divested by Strides had sales […]

Strides Shasun to launch allergy drug in the US

Pharma company Strides Shasun said it had received approval allergy drug Cetirizine Hydrochloride in the US. “The US market for Cetirizine Hydrochloride Capsules (Softgel) is approximately USD 60 mln, with only one other generic player,” the company said. “The product is ready for launch immediately and as in the case of OTC products, the market […]

Strides Shasun gets USFDA nod for nausea drug

Pharmaceutical company Strides Shasun said it received approval from the United States Food & Drug Administration to sell nausea drug Promethazine Hydrochloride in the country. The US market for Promethazine Hydrochloride tablets is approximately USD 17 Million. It will be sold in three doses ranging from 12.5 mg to 50 mg. Promethazine Hydrochloride Tablet is […]

Stride Shasun receives USFDA approval for constipation treatment

Pharma company Strides Shasun announced that it received the United States Food & Drug Administration (USFDA) approval for Polyethylene Glycol powder to treat occasional constipation. The powder when consumed as a solution works by softening the stool and increasing the frequency of bowel movement by retaining water in the stool, added the company. Yeterday the […]

Stride Shasun receives USFDA Approval for Ranitidine Tablets

Pharma company Strides Shasun announced that it received the United States Food & Drug Administration (USFDA) approval for generic Ranitidine Tablets, used to treat and prevent ulcers in the stomach and intestines. Ranitidine tablet is the first integrated product approval post merger of Strides and Shasun in 2015. The active ingredient and formulations will be […]